01/04/2020 Budesonide prolonged-release tablet for treating mild to moderate active ulcerative colitis
NRThe Ministry of Health’s Drug Advisory Committee has not recommended listing budesonide prolonged-release 9 mg tablet on the Medication Assistance Fund (MAF) for treating mild to moderate active ulcerative colitis because of uncertain comparative effectiveness and unfavourable cost effectiveness compared to alternative treatment options.